AstraZeneca pauses £200m investment in Cambridge research site

<p>Decision means none of drugmaker’s much-trumpeted £650m UK investment package is currently proceeding</p><p>The drugmaker AstraZeneca has paused a planned £200m investment in its Cambridge research site, completing a depressing week for the UK pharmaceutical industry.</p><p>The decision by Britain’s biggest company means none of its <a href="https://www.gov.uk/government/news/astrazeneca-plans-650-million-investment-in-uk">much-trumpeted £650m investment package in the UK</a> – which was originally announced in March 2024 – is currently proceeding.</p> <a href="https://www.theguardian.com/business/2025/sep/12/astrazeneca-pauses-200m-investment-in-cambridge-research-site">Continue reading...</a>